{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T04:08:20Z","timestamp":1746072500804,"version":"3.40.4"},"reference-count":18,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,31]],"date-time":"2025-01-31T00:00:00Z","timestamp":1738281600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["valuehealthregionalissues.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Value in Health Regional Issues"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1016\/j.vhri.2025.101098","type":"journal-article","created":{"date-parts":[[2025,3,6]],"date-time":"2025-03-06T19:45:23Z","timestamp":1741290323000},"page":"101098","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Estimation of the Effects and Costs of Lifestyle Intervention and Treatment With Voglibose in the Japanese Prediabetic Population: A Cost-Effectiveness Analysis"],"prefix":"10.1016","volume":"47","author":[{"given":"Mio","family":"Ezura","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shota","family":"Saito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masahiro","family":"Ishizawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuya","family":"Fujihara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hirohito","family":"Sone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kohei","family":"Akazawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.vhri.2025.101098_bib2","doi-asserted-by":"crossref","first-page":"753","DOI":"10.2337\/dc07-9920","article-title":"Impaired fasting glucose and impaired glucose tolerance: implications for care","volume":"30","author":"Nathan","year":"2007","journal-title":"Diabetes Care"},{"issue":"1","key":"10.1016\/j.vhri.2025.101098_bib3","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.ecl.2017.10.001","article-title":"Prediabetes and cardiovascular disease: pathophysiology and interventions for prevention and risk reduction","volume":"47","author":"Brannick","year":"2018","journal-title":"Endocrinol Metab Clin North Am"},{"issue":"1","key":"10.1016\/j.vhri.2025.101098_bib4","doi-asserted-by":"crossref","DOI":"10.1136\/bmjdrc-2019-001061","article-title":"Association between pre-diabetes and microvascular and macrovascular disease in newly diagnosed type 2 diabetes","volume":"8","author":"Palladino","year":"2020","journal-title":"BMJ Open Diabetes Res Care"},{"key":"10.1016\/j.vhri.2025.101098_bib5","doi-asserted-by":"crossref","first-page":"455","DOI":"10.3389\/fendo.2019.00455","article-title":"Effects of lifestyle modification and anti-diabetic medicine on prediabetes progress: a systematic review and meta-analysis","volume":"10","author":"Sheng","year":"2019","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/j.vhri.2025.101098_bib6","first-page":"173","article-title":"Therapeutic interventions to reduce the risk of progression from prediabetes to type 2 diabetes mellitus","volume":"10","author":"Portero McLellan","year":"2014","journal-title":"Ther Clin Risk Manag"},{"issue":"9675","key":"10.1016\/j.vhri.2025.101098_bib7","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1016\/S0140-6736(09)60222-1","article-title":"Voglibose for prevention of type 2 diabetes mellitus: a randomised, double-blind trial in Japanese individuals with impaired glucose tolerance","volume":"373","author":"Kawamori","year":"2009","journal-title":"Lancet"},{"issue":"suppl 1","key":"10.1016\/j.vhri.2025.101098_bib8","doi-asserted-by":"crossref","first-page":"S10","DOI":"10.1016\/j.jcjd.2017.10.003","article-title":"Definition, classification and diagnosis of diabetes, prediabetes and metabolic syndrome","volume":"42","author":"Punthakee","year":"2018","journal-title":"Can J Diabetes"},{"issue":"6","key":"10.1016\/j.vhri.2025.101098_bib10","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1111\/j.2040-1124.2010.00052.x","article-title":"Cost-effectiveness analysis of voglibose for prevention of type 2 diabetes mellitus in Japanese patients with impaired glucose tolerance","volume":"1","author":"Ikeda","year":"2010","journal-title":"J\u00a0Diabetes Investig"},{"issue":"6","key":"10.1016\/j.vhri.2025.101098_bib11","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.jdiacomp.2019.03.008","article-title":"The impact of sex on risk of cardiovascular disease and all-cause mortality in adults with or without diabetes mellitus: a comparison between the U.S. and Japan","volume":"33","author":"Liu","year":"2019","journal-title":"J\u00a0Diabetes Complications"},{"key":"10.1016\/j.vhri.2025.101098_bib13","article-title":"Association between prediabetes and risk of cardiovascular disease and all cause mortality: systematic review and meta-analysis","volume":"355","author":"Huang","year":"2016","journal-title":"BMJ"},{"issue":"2","key":"10.1016\/j.vhri.2025.101098_bib15","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.pcd.2011.10.006","article-title":"Cost and clinical implications of diabetes prevention in an Australian setting: a long-term modeling analysis","volume":"6","author":"Palmer","year":"2012","journal-title":"Prim Care Diabetes"},{"issue":"1","key":"10.1016\/j.vhri.2025.101098_bib16","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/s12902-018-0261-3","article-title":"Comparison of health-related quality of Life (HRQOL) among patients with pre-diabetes, diabetes and normal glucose tolerance, using the 15D-HRQOL questionnaire in Greece: the DEPLAN study","volume":"18","author":"Makrilakis","year":"2018","journal-title":"BMC Endocr Disord"},{"key":"10.1016\/j.vhri.2025.101098_bib18","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/1478-7547-11-22","article-title":"WTP for a QALY and health states: more money for severer health states?","volume":"11","author":"Shiroiwa","year":"2013","journal-title":"Cost Eff Resour Alloc"},{"issue":"6","key":"10.1016\/j.vhri.2025.101098_bib19","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1056\/NEJMoa012512","article-title":"Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin","volume":"346","author":"Knowler","year":"2002","journal-title":"N\u00a0Engl J Med"},{"issue":"9626","key":"10.1016\/j.vhri.2025.101098_bib20","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1016\/S0140-6736(08)60766-7","article-title":"The long-term effect of lifestyle interventions to prevent diabetes in the China Da Qing Diabetes Prevention Study: a 20-year follow-up study","volume":"371","author":"Li","year":"2008","journal-title":"Lancet"},{"issue":"20","key":"10.1016\/j.vhri.2025.101098_bib21","doi-asserted-by":"crossref","first-page":"7454","DOI":"10.3390\/ijerph17207454","article-title":"Motivation and barriers to maintaining lifestyle changes in patients with type 2 diabetes after an intensive lifestyle intervention (the U-TURN Trial): a longitudinal qualitative study","volume":"17","author":"Schmidt","year":"2020","journal-title":"Int J Environ Res Public Health"},{"key":"10.1016\/j.vhri.2025.101098_bib22","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s40842-015-0009-1","article-title":"The cost-effectiveness of diabetes prevention: results from the diabetes prevention program and the diabetes prevention program outcomes study","volume":"1","author":"Herman","year":"2015","journal-title":"Clin Diabetes Endocrinol"},{"issue":"12","key":"10.1016\/j.vhri.2025.101098_bib23","doi-asserted-by":"crossref","first-page":"2016","DOI":"10.1248\/bpb.b19-00505","article-title":"Characteristics and early hypoglycemic medications of patients at risk of progression to type 2 diabetes in Japan: a retrospective cohort study of health checkup and claims data","volume":"42","author":"Kanai","year":"2019","journal-title":"Biol Pharm Bull"}],"container-title":["Value in Health Regional Issues"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2212109925000238?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2212109925000238?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,4,30]],"date-time":"2025-04-30T04:05:29Z","timestamp":1745985929000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2212109925000238"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5]]},"references-count":18,"alternative-id":["S2212109925000238"],"URL":"https:\/\/doi.org\/10.1016\/j.vhri.2025.101098","relation":{},"ISSN":["2212-1099"],"issn-type":[{"type":"print","value":"2212-1099"}],"subject":[],"published":{"date-parts":[[2025,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Estimation of the Effects and Costs of Lifestyle Intervention and Treatment With Voglibose in the Japanese Prediabetic Population: A Cost-Effectiveness Analysis","name":"articletitle","label":"Article Title"},{"value":"Value in Health Regional Issues","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vhri.2025.101098","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc. on behalf of International Society for Pharmacoeconomics and Outcomes Research, Inc.","name":"copyright","label":"Copyright"}],"article-number":"101098"}}